Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-06

Clinical Trial Update: 5-HIAA in Urine Versus 5-HIAA in Plasma Patients With a Serotonin Producing Neuroendocrine Tumor'

View source ↗

Summary

This completed clinical trial evaluated 5-HIAA levels in urine versus plasma in patients with serotonin-producing neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Medical Center Groningen | Conditions: Neuroendocrine Tumors | Status: COMPLETED